“…Both CRMP2 and moesin associate with microtubules to bring them into proximity with the cell membrane. CRMP2 is regulated in the brain during development and aging (Cnops et al, 2004; Cnops et al, 2006; Fountoulakis et al, 2000; Hamajima et al, 1996; Poon et al, 2004; Poon et al, 2006; Veyrac et al, 2005), as well as in a variety of neuropathologic conditions (Bretin et al, 2006; Carrette et al, 2006; Castegna et al, 2002; Chen et al, 2007; Cid et al, 2007; Cole et al, 2004; Cole et al, 2007; Fujisawa et al, 2008; Iwazaki et al, 2007; Lin and Hsueh, 2008; Putman et al, 1997; Ryan and Pimplikar, 2005; Sultana et al, 2007; Vuaillat et al, 2008; Yoshida et al, 1998; Zhang et al, 2007; Zhao et al, 2006). Yet there is much still to be learned about the appearance and function of this highly regulated mediator of neuroplasticity in the injured and aging brain.…”